MannKind Provides Update on Senior Management
May 30, 2017 13:15 pm UTC| Business
VALENCIA, Calif., May 30, 2017 -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) announced today that its Board of Directors appointed Michael Castagna, Pharm.D., as Chief Executive Officer effective May 25, 2017. Dr....
MannKind Provides Update on Senior Management
May 30, 2017 13:15 pm UTC| Business
VALENCIA, Calif., May 30, 2017 -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) announced today that its Board of Directors appointed Michael Castagna, Pharm.D., as Chief Executive Officer effective May 25, 2017. Dr....
MannKind Provides Update on Senior Management
May 30, 2017 13:15 pm UTC| Business
VALENCIA, Calif., May 30, 2017 -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) announced today that its Board of Directors appointed Michael Castagna, Pharm.D., as Chief Executive Officer effective May 25, 2017. Dr....
MannKind Provides Update on Senior Management
May 30, 2017 13:15 pm UTC| Business
VALENCIA, Calif., May 30, 2017 -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) announced today that its Board of Directors appointed Michael Castagna, Pharm.D., as Chief Executive Officer effective May 25, 2017. Dr....
MannKind Provides Update on Senior Management
May 30, 2017 13:15 pm UTC| Business
VALENCIA, Calif., May 30, 2017 -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) announced today that its Board of Directors appointed Michael Castagna, Pharm.D., as Chief Executive Officer effective May 25, 2017. Dr....
MannKind Provides Update on Senior Management
May 30, 2017 13:15 pm UTC| Business
VALENCIA, Calif., May 30, 2017 -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) announced today that its Board of Directors appointed Michael Castagna, Pharm.D., as Chief Executive Officer effective May 25, 2017. Dr....
MannKind Provides Update on Senior Management
May 30, 2017 13:15 pm UTC| Business
VALENCIA, Calif., May 30, 2017 -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) announced today that its Board of Directors appointed Michael Castagna, Pharm.D., as Chief Executive Officer effective May 25, 2017. Dr....
Viksit Bharat 2026: Fiscal Muscle, Factory Revival, and the War on Speculation